WB result of Wee1 Recombinant Rabbit mAb
Primary antibody: Wee1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Lane 2: Raji whole cell lysate 20 µg
Lane 3: Jurkat whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 72 kDa
Observed MW: 95 kDa
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | Wee1 |
| Location | Nucleus |
| Accession | P30291 |
| Clone Number | S-6519 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | WB, IHC-P |
| Reactivity | Hu, Ms |
| Positive Sample | HeLa, Raji, Jurkat, NIH/3T3 |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| WB | 1:1000 | Hu, Ms |
| IHC-P | 1:500 | Hu |
Background
Wee1 is a nuclear cell cycle checkpoint kinase that is functionally a tyrosine kinase but is closer in sequence and structure to serine/threonine kinases; its core function is to inhibit CDK1/cyclin B complex activity by phosphorylating CDK1 at Tyr15, thereby preventing cells from prematurely entering mitosis. Structurally, the catalytic kinase domain of Wee1 lies between its N-terminal and C-terminal regulatory domains, and its activity is regulated mainly not through phosphorylation but through transcriptional control and protein degradation that govern protein abundance. In addition to the G2/M checkpoint, Wee1 also participates in coordinating S-phase DNA replication and stabilizing stalled replication forks by phosphorylating and inhibiting CDK2. In cancer therapy, Wee1 is overexpressed in multiple malignancies including hepatocellular carcinoma, breast cancer, glioblastoma, and malignant melanoma and is associated with poor prognosis; p53-deficient tumor cells rely more heavily on the G2 checkpoint for survival because of their loss of the G1 checkpoint, and therefore Wee1 inhibitors (such as AZD1775/MK-1775) can abolish the G2 block, forcing cells carrying unrepaired DNA damage into mitosis and causing mitotic catastrophe, and they show synergistic antitumor effects when combined with radiotherapy and DNA-damaging chemotherapeutic agents.
Picture
Picture
Western Blot
WB result of Wee1 Recombinant Rabbit mAb
Primary antibody: Wee1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: NIH/3T3 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 72 kDa
Observed MW: 95 kDa
This blot was developed with high sensitivity substrate
Immunohistochemistry
IHC shows positive staining in paraffin-embedded human breast. Anti-Wee1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human testis. Anti-Wee1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human tonsil. Anti-Wee1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
IHC shows positive staining in paraffin-embedded human colon cancer. Anti-Wee1 antibody was used at 1/500 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.
